Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ceci

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Clinical Nuclear Medicine|May 24, 2013
11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT studyFrancesco Ceci, Riccardo Schiavina, Paolo Castellucci, et al.
Clinical Nuclear Medicine|June 26, 2013
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mLMarcelo Mamede, Francesco Ceci, Paolo Castellucci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2015
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?Francesco Ceci, Christian Uprimny, Bernhard Nilica, et al.
Clinical Genitourinary Cancer|October 9, 2018
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by <sup>68</sup>Ga-PSMA-11 PET/CTGiulia Polverari, Francesco Ceci, Martin Allen-Auerbach, et al.
EJNMMI Research|October 16, 2020
[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trialGiulia Polverari, Francesco Ceci, Roberto Passera, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2023
[<sup>18</sup>F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell CarcinomaLighea Simona Airò Farulla, Laura Lavinia Travaini, Mariarosaria Cuomo, et al.
Annals of Surgical Oncology|May 9, 2024
ASO Author Reflections: Radio-Guided Surgery in Small Intestine Neuroendocrine Tumors: New Probe, New Perspectives?Emilio Bertani, Francesco Mattana, Francesco Collamati, et al.
Journal of Clinical Medicine|November 13, 2021
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced MelanomaVirginia Liberini, Marco Rubatto, Riccardo Mimmo, et al.
Biomedicines|February 25, 2023
First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine TumorLorenzo Muraglia, Francesco Mattana, Laura Lavinia Travaini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Clinical Nuclear Medicine|May 24, 2013
11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT studyFrancesco Ceci, Riccardo Schiavina, Paolo Castellucci, et al.
Clinical Nuclear Medicine|June 26, 2013
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mLMarcelo Mamede, Francesco Ceci, Paolo Castellucci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2015
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?Francesco Ceci, Christian Uprimny, Bernhard Nilica, et al.
Clinical Genitourinary Cancer|October 9, 2018
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by <sup>68</sup>Ga-PSMA-11 PET/CTGiulia Polverari, Francesco Ceci, Martin Allen-Auerbach, et al.
EJNMMI Research|October 16, 2020
[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trialGiulia Polverari, Francesco Ceci, Roberto Passera, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2023
[<sup>18</sup>F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell CarcinomaLighea Simona Airò Farulla, Laura Lavinia Travaini, Mariarosaria Cuomo, et al.
Annals of Surgical Oncology|May 9, 2024
ASO Author Reflections: Radio-Guided Surgery in Small Intestine Neuroendocrine Tumors: New Probe, New Perspectives?Emilio Bertani, Francesco Mattana, Francesco Collamati, et al.
Journal of Clinical Medicine|November 13, 2021
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced MelanomaVirginia Liberini, Marco Rubatto, Riccardo Mimmo, et al.
Biomedicines|February 25, 2023
First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine TumorLorenzo Muraglia, Francesco Mattana, Laura Lavinia Travaini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Pageof 15